3-124049075-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1
The NM_001388419.1(KALRN):c.73+15262T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.74 in 152,122 control chromosomes in the GnomAD database, including 42,641 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.74 ( 42641 hom., cov: 32)
Consequence
KALRN
NM_001388419.1 intron
NM_001388419.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.17
Publications
0 publications found
Genes affected
KALRN (HGNC:4814): (kalirin RhoGEF kinase) Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with the huntingtin-associated protein 1, which is a huntingtin binding protein that may function in vesicle trafficking. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.834 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KALRN | NM_001388419.1 | c.73+15262T>G | intron_variant | Intron 1 of 59 | ENST00000682506.1 | NP_001375348.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KALRN | ENST00000682506.1 | c.73+15262T>G | intron_variant | Intron 1 of 59 | NM_001388419.1 | ENSP00000508359.1 | ||||
| KALRN | ENST00000683571.1 | c.73+15262T>G | intron_variant | Intron 1 of 3 | ENSP00000506888.1 | |||||
| KALRN | ENST00000682861.1 | c.73+15262T>G | intron_variant | Intron 1 of 1 | ENSP00000506756.1 |
Frequencies
GnomAD3 genomes AF: 0.740 AC: 112441AN: 152002Hom.: 42619 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
112441
AN:
152002
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.740 AC: 112505AN: 152122Hom.: 42641 Cov.: 32 AF XY: 0.736 AC XY: 54765AN XY: 74370 show subpopulations
GnomAD4 genome
AF:
AC:
112505
AN:
152122
Hom.:
Cov.:
32
AF XY:
AC XY:
54765
AN XY:
74370
show subpopulations
African (AFR)
AF:
AC:
24046
AN:
41466
American (AMR)
AF:
AC:
11336
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
2900
AN:
3470
East Asian (EAS)
AF:
AC:
2698
AN:
5170
South Asian (SAS)
AF:
AC:
3587
AN:
4806
European-Finnish (FIN)
AF:
AC:
8319
AN:
10594
Middle Eastern (MID)
AF:
AC:
241
AN:
294
European-Non Finnish (NFE)
AF:
AC:
57100
AN:
68006
Other (OTH)
AF:
AC:
1548
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1435
2870
4304
5739
7174
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
844
1688
2532
3376
4220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2121
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.